Last year, Trinseo (NYSE: TSE), a global materials solutions provider and manufacturer of plastics, latex binders and synthetic rubber, began supporting the Drug Delivery Devices market with its specialty engineered resins. The company has highlighted its materials at trade shows worldwide including MD&M West in California, Pharmapack in Paris, and the International Component Manufacturing and Design Show in Shanghai.
Trinseo will be showcasing its plastic resins at Medtec Europe in Stuttgart from April 17 to 19, co-located with one of its European distributor partners VELOX in Hall 9, Booth 9E38.
Typical drug delivery devices, also known as pre-filled or combination devices that can use Trinseo materials include auto injectors, insulin pens, asthma inhalers, prefilled syringes and wearable devices. The company’s specialty compounded solutions are ideal for a wide range of applications – MAGNUM™ ABS, CALIBRE™ Polycarbonate, STYRON Polystyrene, and EMERGE™ Advanced Resins for rigid plastic applications, and RAPLAN™ and MEGOL™ Thermoplastic Elastomers for soft touch and over molding needs.
Trinseo is ISO 13485 certified and a trusted partner of global product designers, manufacturers and molders of medical devices. Large and global in its infrastructure yet agile in its service model, the company is known for its quality, technical knowledge, and regulatory support services, which enable customers to lower risk and take products to market sooner.
As the healthcare industry continues to look for ways to enhance patient care, improve quality of life, and reduce costs, self-administered therapies are providing a viable solution. Health care providers need devices that are effective therapeutically and also are convenient, functional and aesthetically pleasing. Plastic resin materials are a big part of the solution. Trinseo, with nearly three decades of experience with medical polymers, is supporting global customers with this challenge.
Trinseo (NYSE:TSE) is a global materials solutions provider and manufacturer of plastics, latex binders, and synthetic rubber with a focus on delivering innovative, sustainable, and value-creating products that are intrinsic to our daily lives. Trinseo is dedicated to making a positive impact on society by partnering with like-minded stakeholders, and supporting the sustainability goals of our customers in a wide range of end-markets including automotive, consumer electronics, appliances, medical devices, packaging, footwear, carpet, paper and board, building and construction, and tires. Trinseo had approximately $3.0 billion in net sales in 2020, with 17 manufacturing sites around the world, and approximately 2,600 employees. For more information, please visit: www.trinseo.com.
Cautionary Note on Forward-Looking Statements
This press release may contain forward-looking statements including, without limitation, statements concerning plans, objectives, goals, projections, strategies, future events or performance, and underlying assumptions and other statements, which are not statements of historical facts or guarantees or assurances of future performance. Forward-looking statements may be identified by the use of words like "expect," "anticipate," "intend," "forecast," "outlook," "will," "may," "might," "see," "tend," "assume," "potential," "likely," "target," "plan," "contemplate," "seek," "attempt," "should," "could," "would" or expressions of similar meaning. Forward-looking statements reflect management’s evaluation of information currently available and are based on our current expectations and assumptions regarding the timing of the proposed acquisition of the Arkema MMA and PMMA business (the "Acquisition"); estimated and future results of operations, business strategies, competitive position, industry environment and potential growth opportunities and cost synergies relating to the Acquisition, our business, the economy and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict. Factors that might cause such a difference include, but are not limited to, our failure to complete the Acquisition or meet the conditions to closing, including antitrust, works council and other regulatory approvals; the failure to obtain the financing necessary to fund the Acquisition and the impact of the substantial indebtedness to be incurred; costs related to the Acquisition; following the Acquisition, our ability to successfully integrate the acquired businesses, generate expected cost savings and synergies, maintain relationships with customers, retain key employees and profitably grow the business; and those factors discussed in our Annual Report on Form 10-K, under Part I, Item 1A —"Risk Factors" and elsewhere in our other reports, filings and furnishings made with the U.S. Securities and Exchange Commission from time to time. As a result of these or other factors, our actual results may differ materially from those contemplated by the forward-looking statements. Therefore, we caution you against relying on any of these forward-looking statements. The forward-looking statements included in this press release are made only as of the date hereof. We undertake no obligation to publicly update or revise any forward-looking statement as a result of new information, future events or otherwise, except as otherwise required by law.